The history of Viagra, originally marketed by copyright, presents a fascinating case study for investors considering the healthcare arena . While its initial success and impact of countless in earnings , the exclusivity lapse has opened the floodgates for competing medications, significantly eroding profit opportunities. This shift raises doubts ab